Marijuana biotech firm Front Range Biosciences announced Thursday it secured $10 million in private funding to accelerate production in California, Canada and Colorado. The company, based in Lafayette, Colorado, said it plans to invest some of the money in investigating new strains of cannabis. Front Range Biosciences uses tissue-culture technology to make “plantlets” for both […]
This post is from Marijuana Business Daily. We encourage our readers to continue reading the full article from the original source here.